Home > Boards > US Listed > Biotechs > Stemline Therapeutics (STML)

$STML recent news/filings

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stocktrademan Member Profile
 
Followed By 463
Posts 9,969
Boards Moderated 2
Alias Born 04/28/14
160x600 placeholder
Stemline Therapeutics Announces ELZONRIS® Clinical Data Selected for Oral Presentation at the 81st Annual Meeting of the Jap... GlobeNewswire Inc. - 10/8/2019 7:30:00 AM
Stemline Therapeutics Recaps Felezonexor (SL-801) Clinical Data Presentation From ESMO 2019 Congress GlobeNewswire Inc. - 10/1/2019 7:30:00 AM
Stemline Therapeutics Announces Felezonexor (SL-801) Clinical Data to be Featured at Upcoming ESMO 2019 Congress GlobeNewswire Inc. - 9/27/2019 7:30:00 AM
Stemline Therapeutics to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 4:01:00 PM
Stemline Therapeutics to Present at the Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire Inc. - 9/18/2019 9:32:15 AM
Stemline Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire Inc. - 9/5/2019 7:30:00 AM
Stemline Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference GlobeNewswire Inc. - 8/9/2019 4:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/9/2019 1:18:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/9/2019 1:16:29 PM
Stemline Therapeutics Announces Pricing of $76,250,000 Public Offering of Common Stock GlobeNewswire Inc. - 8/8/2019 10:23:47 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/8/2019 6:10:20 AM
Stemline Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire Inc. - 8/7/2019 4:25:03 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 4:37:16 PM
Stemline Therapeutics Announces that CMS Grants New Technology Add-on Payment (NTAP) to ELZONRIS® GlobeNewswire Inc. - 8/6/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/2/2019 7:31:04 AM
Stemline Therapeutics Reports Second Quarter 2019 Financial Results GlobeNewswire Inc. - 8/2/2019 7:00:00 AM
Stemline Therapeutics to Host Conference Call on Second Quarter 2019 Financial Results on August 2, 2019 GlobeNewswire Inc. - 7/29/2019 7:00:00 AM
Stemline Therapeutics Highlights Recent Clinical and Regulatory Developments and Details Upcoming Milestones following its An... GlobeNewswire Inc. - 7/8/2019 5:50:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:18:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:17:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:17:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:17:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:16:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:16:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/28/2019 5:16:09 PM
stocktrademan   Thursday, 07/31/14 02:42:18 PM
Re: None
Post # of 67 
$STML recent news/filings

bullish

## source: finance.yahoo.com

Mon, 28 Jul 2014 16:01:38 GMT ~ STEMLINE THERAPEUTICS INC Files SEC form 8-K, Other Events


read full: http://biz.yahoo.com/e/140728/stml8-k.html
*********************************************************

Mon, 28 Jul 2014 10:12:42 GMT ~ Stemline Therapeutics Announces Opening of SL-401 Corporate IND and Start of Clinical Trials in BPDCN and AML

[at noodls] - Initiation of Broad Clinical Development Program; Potential Accelerated Approval Path in Multiple Indications NEW YORK, July 28, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced ...

read full: http://www.noodls.com/view/E1EA05B7405808E2309AEC3105E1B8D8A0EB327D
*********************************************************

Mon, 28 Jul 2014 10:00:00 GMT ~ Stemline Therapeutics Announces Opening of SL-401 Corporate IND and Start of Clinical Trials in BPDCN and AML

[GlobeNewswire] - NEW YORK -- Stemline Therapeutics, Inc. announced today the opening of its SL-401 Investigational New Drug (IND) and initiation of a broad clinical development program including trials in blastic plasmacytoid ...

read full: http://finance.yahoo.com/news/stemline-therapeutics-announces-opening-sl-100000404.html
*********************************************************

Fri, 18 Jul 2014 14:01:49 GMT ~ Stemline (STML) Enters Oversold Territory


read full: http://finance.yahoo.com/news/stemline-stml-enters-oversold-territory-140149660.html
*********************************************************

Mon, 23 Jun 2014 21:24:36 GMT ~ STEMLINE THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders


read full: http://biz.yahoo.com/e/140623/stml8-k.html
*********************************************************


$STML charts

basic chart ## source: stockcharts.com



basic chart ## source: eoddata.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$STML company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/STML/company-info
Ticker: $STML
OTC Market Place: Not Available
CIK code: not found
Company name: Stemline Therapeutics, Inc.
Incorporated In:

Business Description:


$STML share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$STML extra dd links

Company name: Stemline Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/STML/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/STML/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=STML+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=STML+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=STML+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/STML/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/STML/news - http://finance.yahoo.com/q/h?s=STML+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/STML/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/STML/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/STML/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/STML/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/STML/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/STML/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/STML/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/STML/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=STML+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/STML
DTCC (dtcc.com): http://search2.dtcc.com/?q=Stemline+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Stemline+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Stemline+Therapeutics%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/STML/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/STML
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/STML/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/STML/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/STML/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/STML/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/STML/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/STML/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/STML/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=STML&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=STML
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/STML/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=STML+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=STML+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=STML
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=STML
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=STML+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/STML/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=STML+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/STML.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=STML
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/STML/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/STML/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/STML/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/STML/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/STML
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/STML
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/STML:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=STML
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=STML



$STML DD Notes ~ http://www.ddnotesmaker.com/STML
p100k

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist